• Jan 31, 2025

Neogen (NASDAQ:NEOG) Posts Better-Than-Expected Sales In Q4

Life sciences company Neogen (NASDAQ:NEOG) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $231.3 million. Its non-GAAP profit of $0.11 per share was in line with analysts’ consensus estimates.

  • Jan 31, 2025

US inflation increases in December; consumer spending robust

U.S. inflation increased by the most in eight months in December amid robust consumer spending on goods and services, suggesting the Federal Reserve would probably be in no hurry to resume cutting interest rates soon. While the report from the Commerce Department on Friday showed a modest gain in prices excluding the volatile food and energy components on a monthly basis, the annual increase in the so-called core inflation has not slowed since October. The policy statement accompanying the decision did not include the reference to inflation having "made progress" toward the Fed's 2% target.

  • Jan 31, 2025

Why Deckers (DECK) Stock Is Nosediving

Shares of footwear and apparel conglomerate Deckers (NYSE:DECK) fell 16.8% in the morning session after the company reported mixed fourth quarter results: its full-year revenue guidance slightly missed even though the company raised it. The sales guidance suggested a steady slowdown in growth to the mid-teens. On the other hand, Deckers blew past analysts' constant currency revenue and EPS estimates. Overall, this quarter had some key positives, but the market was expecting even better results.